期刊文献+

口服低分子量非肽类胃素抑制剂阿利克仑的合成研究 被引量:1

下载PDF
导出
摘要 本文通过对胃素抑制剂阿利克仑合成的三个重要中间体(2R)-3-甲基-2-(4-甲氧基-3-(3-甲氧丙氧基)苄基)-1-丁醇(中间体1)、(2S,4E)-异丙基-5-氯-4-戊烯酸甲酯(中间体2)、3-氨基-2,2-二甲基丙酰胺(中间体3)的合成路线分别从原料、反应条件、收率等方面对每条路线优劣进行了评价,以求找到最佳的工业化生产合成路线。
作者 张建西
出处 《北方药学》 2014年第2期61-63,共3页 Journal of North Pharmacy
  • 相关文献

参考文献21

  • 1冷玲颖(编译),孙铁民(审校).阿利克仑aliskiren(Tekturna)[J].中国药物化学杂志,2007,17(6):404-404. 被引量:5
  • 2陈玲,邹栩.世界上市新药[J].中国药科大学学报,2007,38(6):577-578. 被引量:5
  • 3Lindsay KB and Skrydstrup T.Formal total synthesis of the potent renin inhibitor aliskiren: application of a SmI2-promoted acyl- like radical coupling[J].J. Org. Chem. 2006,71 ( 13):4766-4777.
  • 4Dong I-I, et al. Practical synthesis of an orally active renin inhibitor aliskiren[J].Tetrahedron Lett., 2005,46(37 ):6337-6340.
  • 5Dong H,Zhang ZL, Huang JH.et al. Practical synthesis of anorally active renin inhibitor aliskiren [J].Tetrahedron Lett., 2005,46(37 ):6337-6340.
  • 6Helvetica Chimiea Acta, 2003,86 : 2848-2870.
  • 7衡林森,等.高血压药阿利克仑主要中间体化合物的合成方法CN101284769[P],2008-10-15.
  • 8Organic Process Research &Development 2007,11:585-591.
  • 9Ru ger,H.,Stutz'S.,Go"schke, R.,Spindler, F. Maibaum, J.Tetrahedron Lett., 2000,41,10085-10089.
  • 10吴忠忠,梁渠,闫书一,王平.(R)-2-[4-甲氧基-3-(3-甲氧基丙氧基)苄基]-3-甲基丁酸的制备改进[J].化学工程师,2009,23(3):11-13. 被引量:4

二级参考文献14

  • 1张新波,王家龙,张雅娟,叶红.超声波在有机合成中的应用[J].化学试剂,2006,28(10):593-596. 被引量:50
  • 2Hua Dang ; Zhi-Liu Zhang ; Jia-Hui Huang; Rujian Ma ; Shu-Hui Chen and Ge Li. Practical synthesis of an orally active renin inhibitor aliskiren[J].Tetrahedron Letters,2005 ,46: 6337-6340.
  • 3David A. Evans;Thomas C. Britton;and Jon A. Ellman. Contrasterie earboximide hydrolysiswith with Li thiumhydroperoxide [ J ].Tetrahedron Letters, 1987,28(49) :6141-6144.
  • 4Feidman D L,Zelenkofske S,Dinboeck Metal. Use of renin inhibi- tots,alone or in combination with other agents, for treatment of cardiovascular and other diseases[P]. WO, 2007/089731,2007-07- 28.
  • 5Webb R L. Drug combination for treatment of cardiovascular[P]. WO, 2007/056324,2007-05-18.
  • 6Webb R L. Combination chemotherapy containing renining hibi- tors and antiobesity agents for the treatment of dyslipidemia and obesity[P]. WO, 2007/048027,2007-04-26.
  • 7FEIDMAN D L, ZELENKOFSKE S, DINBOECK M, et al. Use of renin inhibitors, alone or in combination with other agents, for treatment of cardiovascular and other diseases: WO, 2005/089731 [P]. 2005 - 09 - 29.
  • 8WEBB R L. Drug combination for treatment of cardiovascular disorders: WO, 2007/056324 [P]. 2007 - 05 - 18.
  • 9WEBB R L. Combination chemotherapy containing renin inhibitors and antiobesity agents for the treatment of dyslipidemia and obesity.. WO, 2007/048027 [ P]. 2007 - 04 - 26.
  • 10LINDSAY K B, SKRYDSTRUP T. Formal total synthesis of the potent renin inhibitor aliskiren: application of a smi2-prorooted acyl-like radical coupling[J]. J Org Chem, 2006, 71 (13) : 4766 - 4777.

共引文献11

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部